Longevity Pipeline
Gordian Biotechnology
In vivo pooled gene therapy screening · Age-related diseases
PreclinicalAAV Gene Therapy
Mechanism
In vivo pooled gene therapy screening
Intervention class
Platform / gene therapy
Indication
Age-related diseases
Stage
Preclinical
Evidence
animal
Funding
VC-backed
Backers
Various
Overview
Runs thousands of gene therapies in single aged animals simultaneously to find what actually works in vivo. Sells the de-risking, not (yet) a drug.
Technology
Gordian Biotechnology works in AAV Gene Therapy — Using a hollowed-out virus to deliver a working gene.
Read the AAV Gene Therapy brief →Related companies
Company website / source ↗ Open the interactive map →
◢ Boom-cycle briefing
Get ahead of the next biotech boom.
New companies, stage changes, deal alerts and fresh tech briefs — one sharp email when the map moves.
Curated biotech intelligence, compiled for orientation — not investment advice. Company stages, deals and figures move fast; verify against ClinicalTrials.gov, company filings and primary sources before acting.